 Chronic kidney disease CKD has a prevalence of 10 in the general population and up to 20 in high-risk groups, such as patients with diabetes. Despite the widespread availability of renal replacement therapy in the western world, mortality of patients with end-stage renal disease ESRD is still high. The life expectancy of patients with renal replacement therapy in Austria is reduced by more than 50. 